Dr Lee Alissandratos

CSIRO Synthetic Biology Future Science Fellow
 +61 2 6125 3490

Profile

Biography

Apostolos (Lee) gained his first degree in ChemEng (MSc) with a Diploma in Biotechnology at the National Technical University of Athens (Ethnicon Metsoveion Polytechneion) for which he was awarded the Thomaidion prize.

He then moved to Scotland and the University of Strathclyde to carry out his doctoral studies on a BASF PhD studentship funded through the Centre of Excellence in Biocatalysis (University of Manchester), and supervised by Peter Halling (Strathclyde) and Sabine Flitsch (Manchester).

Following his PhD award, he undertook mandatory Greek national service and was stationed at the Army Chemical Laboratories (ELOT, ISO standardisation).

Lee then moved to Australia to work with Chris Easton at the Australian National University (RSC) on Industrial & Environmental Biocatalysis projects. These were funded primarily through the CSIRO Biofuels Cluster (Energy Transformed Flasgship) and the Grains Research & Development Corporation.

Since then he has expanded his research into the field of diagnostics for Health and Biosecurity and is currently CSIRO Synthetic Biology Future Science Fellow at ANU.  

Research

Research interests

The use of Biocatalysis and Synthetic Biology to create real-world solutions for some of the most pressing global issues : Global HealthBiosecurityEnergy securitySustainable chemical processes

Areas of expertise

  • Enzymes
  • Biocatalysis And Enzyme Technology
  • Bioprocessing, Bioproduction And Bioproducts
  • Medical Biotechnology Diagnostics (Incl. Biosensors)
  • Agricultural Biotechnology Diagnostics (Incl. Biosensors)
  • Environmental Biotechnology Diagnostics (Incl. Biosensors)
  • Bioremediation

Researcher's projects

Biocatalysis for sustainable chemical processes

We are employing Synthetic Biology to develop new Biocatalysis platforms that will allow application of multi-enzymatic cascades as replacements for unsustainable fossil-based processes. This includes engineering of new and improved enzyme activities using renewable substrates (e.g. CO2, ammonia), optimisation of cofactor-dependent biotransformations, and development of new tools for control of multi-enzymatic reactions in vitro (cell-free metabolic engineering) and in whole-cell. Bioproducts targeted range from platform chemicalsand fuels to green fertilisers to fine chemicals and biologics (therapeutics).

"Just-add-water" nucleic acid amplification

The use of Synthetic Biology to assemble biological components into customised useful devices is now a reality. We are employing these principles for the delivery of bio-devices that carry out pathogen nucleic acid amplification and formulating these into stable "just-add-water" formats to produce novel user-friendly, low-cost diagnostic kits that may be applied within primary laboratory settings and at point-of-care. We aim to deliver real-world solutions that may be utilised in low-tech settings in the developing world and remote Australia.  

DNA biosensors 

DNA-based biotechnologies are rapidly forming a new landscape in the world of technology and innovation. However accurate identification of a specific DNA-sequence (e.g. as produced through nucleic acid amplification) still requires high-end equipment and complex protocols. Together with colleagues at the CSIRO (Health & Biosecurity) we are harnessing the power of biological recognition for the production of new biosensors that are able to rapidly identify specific ds-DNA sequences. These allow accurate detection/quantitation of a target DNA sequence and are amenable to application with low-cost analytical technologies in primary laboratories and at point-of-care.

Projects and Grants

Related websites

Publications

Updated:  24 September 2018/Responsible Officer:  Director, RSC/Page Contact:  Web Admin, RSC